Sun Pharma Is Said to Mull Bid for Women’s Wellness Firm Organon

Sun Pharmaceutical Industries Ltd. is talking with advisers about a possible bid for New York-listed wellness company Organon & Co., according to people familiar with the matter.

India’s biggest pharmaceutical company, with a market capitalization of $43 billion, has held preliminary discussions with global lenders to arrange financing for a possible deal, the people said, asking not to be identified because the information is private.

Considerations are preliminary and Sun Pharma may decide to not pursue a bid, the people said. There could also be other suitors for Organon, they said.

The Economic Times reported Sun Pharma’s interest in ...